Bloomin' Brands, Inc. (BLMN) · Aug 5, 2026 · Company update

Earnings beat decisively and full-year profit outlook rises; Q3 remains loss-making.

Earnings beat decisively and full-year profit outlook rises; Q3 remains loss-making.

The quarter cleared the standing earnings bar by a wide margin. Adjusted diluted EPS of $0.39 was above the published Q2 consensus of roughly $0.28–$0.30; even GAAP diluted EPS from continuing operations was $0.37. Revenue, however, was essentially in line with the roughly $1.00–$1.02 billion expectation rather than a major sales surprise. The upside was therefore principally better profitability, not a breakout in total sales.

MetricQ2 2026Q2 2025Expectation / comparison
Total revenue$1.016B$1.002BRoughly in line with published ~$1.00–$1.02B consensus (Financial Highlights; Table One)
Adjusted diluted EPS, continuing operations$0.39$0.32Above published ~$0.28–$0.30 consensus (Table Six)
GAAP diluted EPS, continuing operations$0.37$0.29Up $0.08 year over year (Table One)
U.S. comparable sales+2.3%-0.1%Above the prior full-year midpoint of +1.5% (Table Eight; Fiscal 2026 Outlook)
Restaurant-level operating margin12.4%12.0%+40 basis points (Financial Highlights; Table Four)
Full-year adjusted EPS outlook$0.90–$1.00Prior: $0.75–$0.90Midpoint rises $0.125, above the prior published ~$0.83 consensus (Fiscal 2026 Outlook)
Q3 adjusted EPS outlook$(0.27)–$(0.22)—A planned seasonal loss (Q3 2026 Outlook)

The guidance increase is the more important change in expectations. Management lifted its full-year adjusted EPS range by $0.15 at both ends, taking the midpoint to $0.95 from $0.825. That is not merely a reaffirmation of the turnaround case: it resets the year’s expected profitability materially higher and exceeds the prior published full-year consensus near $0.83 (Fiscal 2026 Outlook).

Sales improved, but the recovery is still pricing-led rather than traffic-led. Combined U.S. comparable sales rose 2.3%, with every major brand positive and Bonefish up 8.1%. Yet total U.S. traffic still fell 1.9%, while average check per person rose 4.2%. In plain terms, customers spent more per visit, but the company still served fewer guests overall; that keeps the underlying demand picture less robust than the headline sales number suggests (Table Eight).

Margin progress was real, though not all of it came from restaurants. Restaurant-level margin expanded 40 basis points to 12.4%, supported by pricing, productivity and lower pre-opening and health-insurance costs. Consolidated adjusted operating margin rose 50 basis points to 4.0%, while lower corporate expense also helped offset a slight decline in U.S. segment operating income before adjustments. The earnings beat is therefore credible, but it reflects cost execution as much as volume growth (Financial Highlights; Tables Two, Four and Five).

The near-term cadence remains uneven. The company’s Q3 outlook calls for an adjusted loss of $0.22–$0.27 per share, so the raised full-year target does not imply a straight-line improvement each quarter. Net, the filing is strongly better than the market’s pre-report earnings and full-year expectations, while negative traffic and the expected Q3 loss remain the key limits on how broad the operating recovery is.

Original filing on SEC EDGAR

More Bloomin' Brands, Inc. news

Earnings beat decisively and full-year profit outlook rises; Q3 remains loss-making. | BLMN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.